Related Experiment Video
Updated: Aug 1, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
Hypertonic Saline vs. Mannitol in Management of Elevated Intracranial Pressure in Children: A Meta-Analysis
Nihar Ranjan Mishra1, Amit Agrawal2, Rashmi Ranjan Das3
1Department of Pediatrics, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
Insights
Hypertonic saline and mannitol show no significant difference in reducing elevated intracranial pressure (ICP) in children. Evidence for mortality is low certainty, necessitating further high-quality trials.
Area of Science:
- Pediatric Critical Care Medicine
- Neuroscience
- Pharmacology
Background:
- Elevated intracranial pressure (ICP) is a critical condition in children, often managed with hyperosmolar agents.
- Hypertonic saline and mannitol are commonly used, but their comparative efficacy and safety in pediatric populations require clear evidence.
Approach:
- A meta-analysis of four randomized controlled trials (RCTs) involving 365 pediatric patients was conducted.
- The GRADE system assessed the certainty of evidence for primary (mortality) and secondary outcomes.
- Searches were performed across relevant databases up to May 31, 2022.
Key Points:
- No significant difference in mortality rates was observed between hypertonic saline and mannitol groups (RR 1.09, 95% CI 0.74-1.6).
- Serum osmolality was significantly higher with mannitol. Adverse events included higher rates of shock and dehydration with mannitol, and hypernatremia with hypertonic saline.
- Certainty of evidence for mortality was low; for secondary outcomes, it ranged from very-low to moderate.
Conclusions:
- Hypertonic saline and mannitol appear comparable for reducing elevated ICP in children, with no significant impact on mortality.
- Current evidence is limited, highlighting the need for high-quality RCTs to guide clinical recommendations.
- Further research is essential to definitively establish optimal treatment strategies and safety profiles.
Objective:
To compare the efficacy and safety of two hyperosmolar agents (hypertonic saline vs. mannitol) used for the reduction of elevated intracranial pressure (ICP) in children.
Methods:
A meta-analysis of randomized controlled trials (RCTs) was conducted and GRADE system (Grading of Recommendations, Assessment, Development and Evaluation) of evidence was applied. Relevant databases were searched till 31st May 2022. Primary outcome was mortality rate.
Results:
Of 720 citations retrieved, 4 RCTs were included in the meta-analysis (n = 365, male = 61%). Traumatic and non-traumatic cases of elevated ICP were included. There was no significant difference in the mortality rate between the two groups [relative risk (RR), 1.09; (95% confidence interval (CI), 0.74 to 1.6)]. No significant difference was found for any of the secondary outcomes, except serum osmolality (being significantly higher in mannitol group). Adverse events like shock and dehydration were significantly higher in the mannitol group, and hypernatremia in the hypertonic saline group. The evidence generated for primary outcome was of "low certainty", and for secondary outcomes, it varied from "very-low to moderate certainty".
Conclusions:
There is no significant difference between hypertonic saline and mannitol used for the reduction of elevated ICP in children. The evidence generated for primary outcome (mortality rate) was of "low certainty", and for secondary outcomes, it varied from "very-low to moderate certainty". More data from high-quality RCTs are needed to guide any recommendation.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

